Preventing Symptomatic Central Nervous System Metastasis in EGFR-Mutant Advanced Non-Small Cell Lung Cancer: Comparison of First- and Third-Generation EGFR Tyrosine Kinase Inhibitors

2020 ◽  
Vol 108 (3) ◽  
pp. e751
Author(s):  
Y. Zhou ◽  
J. Ni ◽  
Z. Zhu
Keyword(s):  
Lung Cancer ◽  
Central Nervous System ◽  
Nervous System ◽  
Kinase Inhibitors ◽  
Small Cell ◽  
Third Generation ◽  
Central Nervous System Metastasis ◽  
Small Cell Lung ◽  
Egfr Tyrosine Kinase Inhibitors ◽  
Egfr Mutant

BIM and SHP2 expression levels to predict clinical outcome to EGFR tyrosine kinase inhibitors (TKI) in EGFR-mutant non-small-cell lung cancer (NSCLC) patients (p).

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. e19078-e19078
Author(s):  
Rosario Garcia Campelo ◽  
Teresa Moran ◽  
Felipe Cardenal ◽  
Guillermo Alonso-Jaudenes Curbera ◽  
Enric Carcereny Costa ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Clinical Outcome ◽  
Tyrosine Kinase ◽  
Small Cell Lung Cancer ◽  
Kinase Inhibitors ◽  
Small Cell ◽  
Small Cell Lung ◽  
Egfr Tyrosine Kinase Inhibitors ◽  
Egfr Mutant ◽  
Nsclc Patients
Sign in / Sign up

Export Citation Format

Share Document